The Medical Genome Initiative: moving whole-genome sequencing for rare disease diagnosis to the clinic

Abstract excerpt

Clinical whole-genome sequencing (WGS) offers clear diagnostic benefits for patients with rare disease. However, there are barriers to its widespread adoption, including a lack of standards for clinical practice. The Medical Genome Initiative consortium was formed to provide practical guidance and support the development of standards for the use of clinical WGS.

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Genetic factors in colorectal cancer
• Share to Genomic variations and chromosomal abnormalities
• Share to Genomics and Rare Diseases